EUVIMEDEUVIMED entdecken
Crossref

Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy

Yongcan Li, Jinqun Gan iD, Jiaqi Lei, Shaolong Qi iD, Xinyang Yu, Weibing Zhang, Yunxuan Feng, Yundong Zhang, Meiqi Cheng, Lie Ma iD, Zhengwei Mao iD, Zhida Liu und 1 weitere

ACS Nano · 2025

DOI: 10.1021/acsnano.4c14517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Yongcan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Immunotherapy, RNA, Circular, Lipids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesImmunotherapyRNA, CircularLipidsInterleukin-12CytokinesAnimalsHumansMiceCell Line, TumorParticle SizeReactive Oxygen SpeciesLiposomes

Stichwörter der Autor:innen

RNA therapyhybrid delivery systeminterleukin-12lipid nanoparticlestrimanganese tetraoxide nanoparticles

Substanzen

RNA, CircularLipidsInterleukin-12CytokinesReactive Oxygen SpeciesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China.
  • Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, P. R. China.

ORCID-Profile: Jinqun Gan, Shaolong Qi, Lie Ma, Zhengwei Mao, Guocan Yu

Förderung

  • National Key Research and Development Program of China
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Natural Science Foundation of China
  • Shanghai Institute for Advanced Study, Zhejiang University

Zitieren

APA

Li, Y., Gan, J., Lei, J., Qi, S., Yu, X., Zhang, W., Feng, Y., Zhang, Y., Cheng, M., Ma, L., Mao, Z., Liu, Z., & Yu, G. (2025). Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c14517

Vancouver

Li Y, Gan J, Lei J, Qi S, Yu X, Zhang W, et al. Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy. ACS Nano. 2025. doi:10.1021/acsnano.4c14517

BibTeX
@article{Li2025,
  author = {Li, Yongcan and Gan, Jinqun and Lei, Jiaqi and Qi, Shaolong and Yu, Xinyang and Zhang, Weibing and Feng, Yunxuan and Zhang, Yundong and Cheng, Meiqi and Ma, Lie and Mao, Zhengwei and Liu, Zhida and Yu, Guocan},
  title = {Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c14517}
}
Kostenlos starten →